Re: Broker Meeting 23 Feb
in response to
by
posted on
Mar 01, 2017 02:01PM
"58% Chance that this Phase 3 BETonMACE will be successful" and "64% probability of apabetalone sales for indications in the BETonMACE trial" arent' exactly the same thing. Split the difference and call it 61%. Either way, it's all a guessing game in my opinion until Q3/Q4 when we get past the futility analysis.
BearDownAZ